Breast Cancer
Arimidex potential in treating postmenopausal women with early breast cancer
Published in Women's Health Weekly, July 25th, 2002
Research results published in The Lancet, provide important details on the potential for Arimidex (anastrazole) in the treatment of early breast cancer in postmenopausal women. The findings, reported in the journal's June 22, 2002, issue, are the first major peer-reviewed publication of the results of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial, the world's largest adjuvant breast cancer study of more than 9300 postmenopausal women in 21 countries.
Results from the ATAC trial were first presented at the San Antonio Breast Cancer Symposium in December 2001 and covered data regarding reduction in risk of disease recurrence and safety profile of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Gynecology
Unnecessary hysterectomy more likely for less affluent women - Menopause
National study halted since health risks exceed benefits in postmenopausal women on estrogen - AIDS and HIV Therapy
Isotretinoin has little impact on cervical cancer risk - Contraception
Few women regret sterilization procedures - Ovarian Cancer
Multiple dose gene therapy yields best results in recurrent ovarian cancer - Bone Health
Estrogen increases jawbone density in postmenopausal women - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
